Current Enterprise Value (EV)
Current share price (P) | $107.73 |
No. shares of common stock outstanding | 623,207,437 |
US$ in thousands | |
Common equity (market value)1 | 67,138,137) |
Add: Preferred stock, $.01 par value, no shares outstanding (per books) | —) |
Total equity | 67,138,137) |
Add: Short-term debt (per books) | —) |
Add: Long-term debt (per books) | 595,700) |
Total equity and debt | 67,733,837) |
Less: Cash and cash equivalents | 862,800) |
Less: Short-term investments | 604,000) |
Enterprise value (EV) | 66,267,037) |
Based on: 10-K (reporting date: 2021-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 107.73 × 623,207,437
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Edwards Lifesciences Corp. Annual Report.
3 2021 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 107.73 × 623,207,437
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Edwards Lifesciences Corp. EV increased from 2019 to 2020 and from 2020 to 2021. |